28/08/2025 07:57
EQS-Adhoc: QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled convertible bonds
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: QIAGEN N.V. / Key words: Issue of Debtbr/ QIAGEN N.V.: QIAGEN N.V. launches nonUS offering of net share settled convertible bonds br/br/ 28Aug2025 / 07:57 CET/CESTbr/ Disclosure of an inside information... Lire...
07/05/2025 14:35
EQS-Adhoc: QIAGEN N.V.: QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: QIAGEN N.V. / Key words: Dividendbr/ QIAGEN N.V.: QIAGEN to propose initiation of annual cash dividend for shareholder approval at Annual General Meeting br/br/ 07May2025 / 14:35 CET/CESTbr/ Disclosure... Lire...
06/04/2025 18:20
EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: QIAGEN N.V. / Key words: Preliminary Resultsbr/ QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates fullyear 2025 adjusted earnings per share outlook br/br/ 06Apr2025 / 18:20... Lire...
12/01/2025 18:55
EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: QIAGEN N.V. / Key words: Share Buybackbr/ QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase br/br/ 12Jan2025 / 18:55 CET/CESTbr/ Disclosure of... Lire...
03/09/2024 07:55
EQS-Adhoc: QIAGEN N.V.: QIAGEN N.V. launches non-US offering of net share settled convertible bonds
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: QIAGEN N.V. / Key words: Bondbr/ QIAGEN N.V.: QIAGEN N.V. launches nonUS offering of net share settled convertible bonds br/br/ 03Sep2024 / 07:55 CET/CESTbr/ Disclosure of an inside information acc. to... Lire...
07/01/2024 19:03
EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: QIAGEN N.V. / Key words: Share Buybackbr/ QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase br/br/ 07Jan2024 / 19:03 CET/CESTbr/ Disclosure of... Lire...
26/07/2022 19:46
QIAGEN N.V.: QIAGEN increases full-year 2022 outlook
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd pDGAPAdhoc: QIAGEN N.V. / Key words: Change in Forecastbr/ QIAGEN N.V.: QIAGEN increases fullyear 2022 outlook br/br/ 26Jul2022 / 19:46 CET/CESTbr/ Disclosure of an inside information acc. to Article 17 MAR of the Regulation... Lire...
26/04/2022 19:57
QIAGEN N.V.: QIAGEN increases full-year 2022 outlook
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd pDGAPAdhoc: QIAGEN N.V. / Key words: Results Forecastbr/ QIAGEN N.V.: QIAGEN increases fullyear 2022 outlook br/br/ 26Apr2022 / 19:57 CET/CESTbr/ Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU... Lire...
12/07/2021 17:13
QIAGEN N.V.: QIAGEN announces preliminary Q2 2021 results and updates 2021 outlook
html xmlns=http://www.w3.org/1999/xhtmlbodytable border=trtd pDGAPAdhoc: QIAGEN N.V. / Key words: Preliminary Results/Change in Forecastbr/ QIAGEN N.V.: QIAGEN announces preliminary Q2 2021 results and updates 2021 outlook br/br/ 12Jul2021 / 17:13 CET/CESTbr/ Disclosure of an inside... Lire...